Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6 Pancreatic Neoplasms 4 Stomach Neoplasms 3 Rectal Neoplasms 2 Colonic Neoplasms 2 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Neutropenia 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Diarrhea 1 Colon Cancer Liver Metastasis 1 Carcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Colon Cancer Liver Metastasis × Irinotecan × Clear all

NCT03175016 2017-06-27

DEBIRI-CRLM

Tianjin Medical University Cancer Institute and Hospital

Phase 2/3 Unknown

Gastrointestinal

Colon Cancer Liver Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡